·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
µ¶ÀÚÁ¦º¸
Event
´º½º
Àüü±â»ç
Á¤Ã¥ · ¹ý·ü
Á¦¾à · ¹ÙÀÌ¿À
¾à±¹ · º´¿ø
Ä«µå´º½º
ÆÊTV
À̽´¿µ»ó
DPÃÊ´ë¼®
À̽´Áø´Ü
¾Ë¾Æº¸Àâ
¿ÀÇǴϾð
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
±âÀÚ¼öø
Ưº°±â°í
English
Policy
Opinion
Company
Product
Interview
TVÆÊµµ¶ó
ÆÊTube
ÆÊ¼îÇÎ
³ª´Â¾à»ç´Ù
ÆÊµå¶ó¸¶
ÆÊ¾ÆÄ«µ¥¹Ì
ÃʽÉŬ·¡½º
OTC»ó´ã
Á¦Ç°°ÁÂ
Çмú°ÁÂ
°æ¿µ°ÁÂ
Ä¿¹Â´ÏƼ
ÆÊ¸®Äí¸£Æ®
ä¿ëÁ¤º¸
PHARMARCY
ÀÎÀçÁ¤º¸
DPºÎµ¿»ê
¾à±¹ Q&A
¾à»ç´ëÃâ
¾à»ç½Å¿ë´ëÃâ
¼¼¹«»ó´ã
¼¼¹«·³ë¹«
¹ý·ü»ó´ã
¾à±¹°æ¿µ°úâ¾÷
ÀǾàÀÚ·á½Ç
ÀǾàÇàÁ¤
¾à»ç¾à±¹
ÀǷẴ¿ø
Á¦¾àÀ¯Åë
º¸µµÀÚ·á
ÆÊ½ºÅ¸Å¬·´
ÀÎ»ç · ºÎÀ½
¾à±¹ÀåÅÍ
ȸ»ç¼Ò°³
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
»ç¾÷Á¦ÈÞ
ÀÎÅͳݽŹ®À±¸®°·É
µ¶ÀÚÁ¦º¸
±âÀÚÀ±¸®°·É
ÀÚÀ²¼¾à¼
¿ø°ÝÁö¿ø¿äû
Event & ¼¼¹Ì³ª
Àüü±â»ç
±×·¡ÇÈ
Á¤Ã¥¡¤¹ý·ü
Á¦¾à¡¤¹ÙÀÌ¿À
¾à±¹¡¤º´¿ø
±âȹ¡¤Å½»ç
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
񃯇
񃯇
ÀǾàǰ
³¹¾Ë½Äº°
µ¥Àϸ®ÆÊ Live Search
´Ý±â
´º½º
>
Àüü ±â»ç
Àüü Çìµå¶óÀÎ ±â»ç
Àüü
|
11-08 (±Ý)
|
11-07 (¸ñ)
|
11-06 (¼ö)
|
11-05 (È)
|
11-04 (¿ù)
|
11-03 (ÀÏ)
|
11-02 (Åä)
»ïÀÍÁ¦¾à 'ISO37001' ÀÎÁõ À§ÇÑ ¼±Æ÷½Ä °³ÃÖ
2019-11-05 13:23:39
[µ¥Àϸ®ÆÊ=±èÁø±¸ ±âÀÚ] »ïÀÍÁ¦¾à(´ëÇ¥ À̼¼¿µ¡¤ÀÌÃæÈ¯¡¤±Ç¿µÀÌ)Àº ¼¿ï ¹®Á¤µ¿ º»»ç¿¡¼ ISO 37001(ºÎÆÐ¹æÁö°æ¿µ½Ã½ºÅÛ)ÀÎÁõÀ» À§ÇÑ ¼±Æ÷½ÄÀ» 4ÀÏ °³ÃÖÇß´Ù°í ¹àÇû...
±èÁø±¸ ±âÀÚ
³» ¾à±¹ °è¾à ¾ÈÀüÇұ´Þ¶óÁø ÀÓ´ëÂ÷¹ý Ȱ¿ëÇ϶ó
2019-11-05 12:20:55
[µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] »ó°¡ÀÓ´ëÂ÷º¸È£¹ýÀº ¾à±¹ÀÇ È¯»êº¸Áõ±Ý¿¡ µû¶ó º¸È£ ¹üÀ§¿¡ Â÷À̸¦ µÐ´Ù. ȯ»êº¸Áõ±ÝÀº ¾à±¹ ÀÓ´ë·áÀÇ 100¹è¿¡ º¸Áõ±ÝÀ» ÇÕÇÑ ±Ý¾×À» ¸»ÇÑ´Ù. ...
Á¤ÈïÁØ ±âÀÚ
'Äݸ°¾ËÆ÷' ÀçÆò°¡ Âø¼ö?...½Ä¾àó, À¯È¿¼ºÀÚ·á Á¦Ãâ Áö½Ã
2019-11-05 12:20:52
[µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] ½ÄǰÀǾàǰ¾ÈÀüó°¡ Á¦¾à»çµé¿¡ ³ú±â´É°³¼±Á¦ ¡®Äݸ°¾ËÆ÷¼¼·¹ÀÌÆ®¡¯ ¼ººÐ ÀǾàǰÀÇ À¯È¿¼º ÀÚ·á Á¦ÃâÀ» Áö½ÃÇß´Ù. ÃÖ±Ù ±¹Á¤°¨»ç¿¡¼ Äݸ°¾ËÆ÷...
õ½ÂÇö ±âÀÚ
"¿µ»ó Âï¾î³ù´Ù"...¾à±¹ 12°÷ °ø°¥ Çù¹ÚÇÑ ÆÊÆÄ¶óÄ¡
2019-11-05 12:20:48
[µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ¼¿ï Áß±¸ ¼ÒÀçÀÇ ¾à±¹ 12°÷À» °ø°¥Çù¹ÚÇÑ ÆÊÆÄ¶óÄ¡°¡ Ãâ¸ôÇßÁö¸¸, ¾à»çµéÀÇ ±âÁö¿Í ¾à»çȸÀÇ ºü¸¥ ´ëÀÀÀ¸·Î ÇÇÇØ¸¦ ¸·¾Ò´Ù. 4ÀÏ ¿ÀÀü ÆÊÆÄ...
Á¤ÈïÁØ ±âÀÚ
´ë¿õ '³ªº¸Å¸' ¹Ì±¹ 3ºÐ±â ¸ÅÃâ 153¾ï...Á¡À¯À² 3À§
2019-11-05 12:20:45
[µ¥Àϸ®ÆÊ=¾È°æÁø ±âÀÚ] ´ë¿õÁ¦¾àÀÌ °³¹ßÇÑ º¸Åø¸®´®µ¶¼ÒÁ¦Á¦ ³ªº¸Å¸°¡ ¹Ì±¹¿¡¼ 153¾ï¿øÀÇ ºÐ±â¸ÅÃâÀ» °Åµ×´Ù. üÇèÇÁ·Î±×·¥À» ÅëÇØ ³ªº¸Å¸¸¦ °æÇèÇÑ ¼ÒºñÀÚµéÀÇ Àç½Ã...
¾È°æÁø ±âÀÚ
Ææº¥´ÙÁ¹ ǰÀýµÇÀÚ Áß°í°Å·¡ ½ÃÀå °¡°Ý 2~3¹è Æøµî
2019-11-05 12:20:40
[µ¥Àϸ®ÆÊ=±è¹Î°Ç ±âÀÚ] °³¡¤°í¾çÀÌ ±¸ÃæÁ¦°¡ ¾à±¹¿¡¼ ǰÀýµÇÀÚ ÀϺÎÀÇ °æ¿ì ¿Â¶óÀÎ Áß°í°Å·¡¸¦ ÅëÇØ ÃÖ´ë 2~3¹è ³ôÀº °¡°Ý¿¡ ÆÈ¸®´Â »óȲÀÌ´Ù. Ç×¾Ï È¿°ú¸¦ ºÃ´Ù´Â ...
±è¹Î°Ç ±âÀÚ
¾à±¹ '³ë¹« ¸®½ºÅ©' ²Ä²ÄÈ÷ ì°Ü¾ß¡¦Á÷¿ø ÁøÁ¤ Áõ°¡¼¼
2019-11-05 12:20:38
[µ¥Àϸ®ÆÊ=±èÁöÀº ±âÀÚ] »ç¾÷ÁÖ¸¦ »ó´ë·Î Á÷¿øÀÌ ³ëµ¿Ã»À̳ª ³ëµ¿À§¿øÈ¸¿¡ ÁøÁ¤À» ³Ö´Â »ç·Ê°¡ ´Ã°í ÀÖ´Â °¡¿îµ¥ ¾à±¹¿¡¼´Â ¾ðÁ¦ ¹ß»ýÇÒÁö ¸ð¸£´Â ¡®³ë¹« ¸®½ºÅ©¡¯¹æÁö...
±èÁöÀº ±âÀÚ
Àü¸³¼± Ä¡·áÁ¦ '¾Æº¸´ÙÆ®' µî ±Þ¿©±âÁØ °È ¹è°æÀº
2019-11-05 12:20:37
[µ¥Àϸ®ÆÊ=ÀÌÇý°æ ±âÀÚ] ÀÌ´ÞºÎÅÍ Àü¸³¼± ºñ´ëÁõ°ú Å»¸ð Ä¡·áÁ¦·Î ¾²ÀÌ´Â 5¾ËÆÄ ȯ¿øÈ¿¼Ò¾ïÁ¦Á¦(ÀÌÇÏ 5ARI) Çdzª±×·»Á¤ 5mg(Çdzª½ºÅ׸®µå)°ú ¾Æº¸´ÙÆ® 0.5mg(µÎŸ½ºÅ׸®...
ÀÌÇý°æ ±âÀÚ
GSK µî ´Ù±¹Àû»ç 2°÷, ÀÓ»ó ºÎÀÛ¿ë Áö¿¬º¸°í °æ°í óºÐ
2019-11-05 12:20:33
[µ¥Àϸ®ÆÊ=ÀÌŹ¼ø ±âÀÚ] Çѱ¹ÈÀÌÀÚÁ¦¾à°ú ±Û¶ô¼Ò½º¹Ì½ºÅ¬¶óÀÎ(GSK)ÀÌ ÀÓ»ó½ÃÇè¿¡¼ ¾à¹°ÀÌ»ó¹ÝÀÀÀ» Áö¿¬º¸°íÇØ °¢°¢ °æ°í óºÐÀ» ¹Þ¾Ò´Ù. ½Ä¾àó´Â ¾à¹° ºÎÀÛ¿ë ...
ÀÌŹ¼ø ±âÀÚ
Ç×ü Ç÷¿ìº´A ȯÀÚ À¯Áö¿ä¹ý... "±Þ¿© û¿ø ´äÇØ¾ß"
2019-11-05 12:20:30
[µ¥Àϸ®ÆÊ=³ëº´Ã¶ ±âÀÚ] 8ÀÎÀÚÀÇ °áÇÌÀ¸·Î ÀÎÇÑ Ç÷¿ìº´A ȯÀÚÀÇ »õ·Î¿î Ä¡·á¿É¼ÇÀ¸·Î Æò°¡¹Þ°í ÀÖ´Â Ç𸮺ê¶óÇÇÇÏÁÖ»çÁ¦°¡ ±Þ¿© °áÁ¤ °¥¸²±æ¿¡ ³õ¿© ÀÖ´Ù. ´çÃÊ ...
³ëº´Ã¶ ±âÀÚ
1
2
3
4
5
ä¿ë
¼Óº¸
ÁÖ¹®½Ã °áÁ¦±Ý¾×ÀÇ 5% Áï½Ã ÇÒÀÎ!
¾ÆÀÌ¿ø Ŭ¸®³Ê¼¼Á¤ 20¸ÅÀÔ
12%
88,825¿ø
¿Ãµ¥ÀÌ KF94 ¸¶½ºÅ©
8%
250¿ø
[µð¶óÀÌÇÁ] 9ÀÎÄ¡ ¼Å§·¹ÀÌÅÍ
48%
23,501¿ø
[µð¶óÀÌÇÁ] ºÐ¸®Çü ¼±Ç³±â+°¡¹æÁõÁ¤
68%
41,500¿ø
¹®¶óÀÌÆ® À¯»ê±Õ
47%
27,930¿ø
[¿À¶óƽ½º] ±¸°À¯»ê±Õ 5°³¿ùºÐ
62%
85,500¿ø
[¶ó¿¤] À¯±â³ó ¼ø¸é »ý¸®´ë
34%
5,605¿ø
[·Îº¸¶ô] F25 RT ¾ÆÄí¾ÆÃ»¼Ò±â
30%
529,000¿ø
[ij¸®¾î] Ŭ¶óÀ©µå 20L Á¦½À±â
46%
299,001¿ø
¿»·Î¿ì¿¡ÀÌÀ¯ ÇÁ·ÎÆú¸®½º
32%
21,280¿ø
[ÇÏÀÌÀ£] ÃÊÀ¯Ãò¾îºí 120Á¤
45%
36,100¿ø
Å»¸ð¼¤Çª1À§¡Ú¸ðÅ彺¼¤Çª
44%
29,450¿ø
µ¥Àϸ®¸®¹öÇコ 90Á¤
22%
11,845¿ø
¾ß»ý ºôº£¸®&¶óÁ¸® 6ÆÑ
25%
32,300¿ø
[·Îº¸¶ô] Qrevo S ·Îº¿Ã»¼Ò±â
42%
870,000¿ø
[Çϸ²] ¿ë°¡¸® ġŲ³Ê°Ù 1+1
38%
17,005¿ø
[¿À¶óƽ½º] ÀÓÇöõƽ½º 5°³¿ùºÐ
61%
118,750¿ø
[ÆÄ¸¶ÇǾÆ] µÎ³ú¿£ Æ÷½ºÆÄƼµô 30Æ÷
25%
13,585¿ø
[Áß¾Ó·¦] Æ÷½ºÆ®¹ÙÀÌ¿Àƽ½º
47%
32,965¿ø
[¸¶´õ½ºÆÊ] ±ÃÁß½ÖȰí 60Æ÷
64%
30,400¿ø
[Ȩ¹ÙÀÌȨ] ³¯°³¾ø´Â ¼±Ç³±â
66%
89,901¿ø
[»ïÇö] ¼Òµ¶¿ë¿¡Åº¿Ã
5%
760¿ø
¹Ù¸£´Â ÆÄ½º Ä𸵠½ºÆ÷Ã÷°Ö
5%
9,500¿ø
[½ÅÀÏ] ¹«¼± 4ÀÎÄ¡ Å×ÀÌºí ¼±Ç³±â
20%
22,500¿ø
¾Ë¸² ¡¤ °øÇ¥
±³À° ¡¤ °ÁÂ
¾à±¹ Q&A
Á¢¼ö ¡¤ ¹®ÀÇ
¾Ë¸²
ºê·¹ÀÌ´×°ú ÇÔ²² Àú¼Ó³ëÈ Æ®·»µå¸¦ º¸´Ù GO ¢º
¾Ë¸²
ÈѽºÅ»¢ç ½´ÆÛÀÚÀÓÀÇ SUPER½ºÆåÆ®·³ & ½Å±Ô Áø¿´ë ¢º
¾Ë¸²
»õ·Î¿öÁø Ç®ÄÉ¾î ÆÐŰÁö&Áø¿´ë POSM ½ÅûÇϱ⠢º
¾Ë¸²
°·ÂÇÑ 1À§ÀÇ ºñ°á! ·Î°ÔÀÎÆû ¸ðÙ¾¸àÅ͸® È®ÀÎÇϱ⠢º
¾Ë¸²
[µ¿¾ÆÁ¦¾à]´ç½ÅÀÇ ÇÏ·ç¿¡ ¾î¶² ¸¶±×³×½·ÀÌ ÇÊ¿äÇѰ¡¿ä?
¸ðÁý
2025³â Á¦¾à¡¤¹ÙÀÌ¿À Á¦¾àÇõ½Å±â¼ú ÄÁ¼³ÆÃ 2Â÷ ¸ðÁý¢º
¾Ë¸²
2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY
°øÇ¥
ÇѰ¸ÞµðÄ® ÀǾà¿Üǰ ȸ¼ö¿¡ °üÇÑ °øÇ¥
¾Ë¸²
īī¿ÀÀÎÁõÀ¸·Î 1ºÐ¸¸¿¡ Á¾Çռҵ漼 °£Æí¿¹Ãø GO ¢º
D-194
ij³ª´Ù¾à»ç ½ÃÇè, ÀÌ·¸°Ô ¹Ù²ï´Ù! ( ~12.31 )
D-194
¾à¾÷°è ´ëÇ¥ ±³À°»çÀÌÆ®, ÆÊŬ·¡½º ( ~12.31 )
ÀÚ»ê°ü¸®
Á¾½Åº¸Çè °è¾àÀÚ¿Ü ¼öÀÍÀÚ º¯°æ °¡´ÉÇѰ¡¿ä?
¾à±¹°æ¿µ°ú â¾÷
ÁÖ¸»¿¡ ¾àÀÌ ¶³¾îÁ³´Ù°í Ç÷¾Ð¾àÀ» ¸ÕÀú ÁÖ¸é ó¹æ
¼¼¹«¡¤³ë¹«
¿¬±Ý°èÁ ¼¼¾×°øÁ¦
¼¼¹«»ó´ã
´ç¼Ò¸ð¼ºÀç·á ó¹æÀÇ ¼¼¹«Ã³¸®°üÇØ ±Ã±ÝÇÑ °ÍÀÌ ÀÖ
¾à±¹´ëÃâ
¾à±¹¿î¿µÀÚ±Ý
¹ý·ü»ó´ã
¾à±¹ °³¼³ °¡´É ¿©ºÎ
±³À° °Á ¹× ¾Ë¸² ±¤°í ¾È³» ÆäÀÌÁö
¿¬¼ö, ±³À°, ¼¼¹Ì³ª, Çмú°Á ¹× ±â¾÷±³À°, ¸ðÁý
°øÇ¥, Åä·Ðȸ, ÀǾàǰ º¯°æ ¾È³» ¹× °¢Á¾ Çà»ç
¾Ë¸² ±¤°í¸¦ ÇØµå¸³´Ï´Ù.
(Á¢¼ö ¹®ÀÇ ¹Ù·Î°¡±â)
¿À´ÃÀÇ
ÇÖ´º½º
1
Àú¿ë·® ·Î¼öÁ¬ ÈÄ¹ß¾à ¹«´õ±â Çã°¡...ƯÇã½ÉÆÇ¸¸ 58°Ç
2
»ó¿ëÈ Áö¸§±æ...K-¹ÙÀÌ¿À, FDA Èñ±Í¾à ÁöÁ¤ °¡¼ÓÈ
3
¾à±¹ ¹®¾Õ ÀǾàǰ ÅÃ¹è ºÐ½Ç¡¤Àýµµ À§Çè Çö½Ç·Î
4
[Ä®·³] »õ Á¤ºÎ º¸°ÇÀÇ·áÁ¤Ã¥¿¡ °Å´Â ±â´ë¿Í ¹Ù¶÷
5
"Äڷγª ŰƮ ´ë·®±¸¸Å ÇÒ°Ô¿ä"...¾à±¹ ³ë¼î»ç±â ±â½Â
6
ºÒ°æ±â ¾à±¹¿¡ ¹Î»ýÁö¿ø±Ý ÈÆÇ³ ºÎ³ª...13.2Á¶ Ç®¸°´Ù
7
SGLT-2, ¸¸¼º ½ÅÀ庴 ±Þ¿©È®´ë¡¦7¿ùºÎÅÍ ´ÙÆÄ¿£Á¤ µî Àû¿ë
8
À¯³ªÀÌÆ¼µå, ½ÅÁ¦Ç° 3Á¾ Ãâ°Ý ´ë±â¡¦¸ÅÃâ 3300¾ï ¸ñÇ¥
9
Áß´ëÀçÇØÃ³¹ú¹ý 3³âÂ÷¡¦Á¦¾à, Çù·Â»ç ¾ÈÀü°ü¸® ½ÃÇè´ë
10
¼ö¹é¾ï Áö¿ø °Å¶á...³ì½ÊÀÚȦµù½º, ÀÚȸ»ç Ư±Þ µµ¿ì¹Ì